Patients with worsening keratoconus can have their progression halted with corneal collagen cross-linking (CXL). Corneal cross-linking works by applying riboflavin drops (vitamin B2) to the cornea, which are then activated by ultraviolet light. This reaction increases the number of cross links between collagen fibres, creating strong, permanent bonds that substantially strengthen the cornea and stop the progression of the disease.
Corneal cross-linking is an advanced procedure for strengthening the cornea and is effective in halting keratoconus progression. The procedure can be performed as an outpatient procedure if you do not have private health insurance. This means you can maximise your medicare rebates with the medicare safety net. If you have health insurance then Dr Cronin performs the procedure in a hospital to minimise the cost of corneal collagen cross linking.
Dr Cronin uses the best collagen cross linking machine available. The revolutionary eye tracking technology in the Glaukos KXL2 topography guided collagen cross linking machine means that more energy is delivered to the steeper parts of your cornea. This personalised and customised treatment is individual for each person. It delivers better vision and better outcomes to more patients. Dr Cronin and his colleagues at QEI are the only surgeons in Australia with this amazing cross linking technology called Glaukos Epioxa.
Sometime people are told that their cornea is “too thin” for corneal collagen cross-linking. This is a very outdated approach. Advanced evidence based cross-linking can be safely performed on thin corneas.